Jane He

Ottawa

Featured in: Favicon

mergermarket.com Favicon

debtwire.com Favicon

ejves.com

info.mergermarket.com

Articles

EQT about to sell Ginko's mainland China business to Advent - sources

Jan 20, 2025 | ionanalytics.com | Eva Ng |Jane He |Keane Hoo

SummaryDeal size will be around USD 1bnEQT opted for carve-out over full entity sale for quicker processEQT is about to sell the mainland China business of Taiwan-based contact lens producer Ginko International to Advent International, said four sources familiar with the situation. The deal size could be over USD 1.1bn, one of the sources said. EQT decided to go ahead with a mainland China carve-out instead of a full entity sale as the process would be quicker.
LVMH’s DFS sale shaping up as summer blockbuster, Morgan Stanley advising - sources

Jun 4, 2024 | ionanalytics.com | Wong Ka-Chun |Arezki Yaiche |Jane He |Eva Ng

LVMH Moët Hennessy Louis Vuitton [EPA:MC]’s sale of DFS Group is likely to take place this summer (Northern Hemisphere) at the earliest, according to four sources familiar with the situation. The EUR 371.2bn (USD 404.9bn)-market cap global luxury goods conglomerate, together with the deal’s sell-side advisor Morgan Stanley, has sounded out some potential bidders in preparation for the proposed sale, which may launch within the next two or three months, they said.
PE and China biotech: Global M&A on the agenda

Jan 16, 2024 | ionanalytics.com | Justin Niessner |Vivian Li |Jane He

As VC hesitates, capital markets cool, valuations correct, and scientific quality improves, big pharma has started making is first acquisitions in China biotech. It looks like the floodgates have opened. They have notThe quality of Chinese biotech has steadily improved in the past 15 years, largely thanks to the “sea turtles” phenomenon of returnee scientists and engineers who studied abroad. This was supported by significant government-backed incubation infrastructure.
High-intensity statin therapy reduces risk of amputation and reintervention among patients undergoing lower extremity bypass for chronic limb-threatening ischemia

Feb 8, 2023 | ejves.com | Jane He |Joshua J. Horns |Larry W. Kraiss |Brigitte Smith

Division of Vascular Surgery, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UTDepartment of Surgery, Surgical Population Analysis Research Core (SPARC), University of Utah School of Medicine, Salt Lake City, UTDepartment of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT